Annora Pharma Private recalls
Annora Pharma Private has 2 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 1 Jul 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is packaging defects.
Total recalls2since 2026
Last 12 months2reported
Class I00% of total
Ongoing2latest 1 Jul 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why annora pharma private is recalled
Product types
Brands
By year
Ongoing annora pharma private recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lacosamide Tablets, USP, C V, 100mg recalled by Annora Pharma PrivateLacosamide | Annora Pharma Private | Packaging Defects | Nationwide |
| Drug | CLASS III | Pitavastatin Tablets, 2 mg recalled by Annora Pharma PrivatePitavastatin Calcium | Annora Pharma Private | Packaging Defects | TN |
All annora pharma private recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lacosamide Tablets, USP, C V, 100mg recalled by Annora Pharma PrivateLacosamide | Annora Pharma Private | Packaging Defects | Nationwide |
| Drug | CLASS III | Pitavastatin Tablets, 2 mg recalled by Annora Pharma PrivatePitavastatin Calcium | Annora Pharma Private | Packaging Defects | TN |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.